Page 16 - Bharat Biotech

Bharat Biotech commences direct supply of 'Covaxin' to 14 states

The company is now getting requests from other state governments as well, and will be processing them for distribution based on availability of the vaccine

Bharat Biotech commences direct supply of Covaxin to 14 states

Bharat Biotech has commenced direct supply of its COVID-19 vaccine 'Covaxin' to 14 states, including Delhi and Maharashtra, with effect from May 1, according to the company's Joint Managing Director Suchitra Ella. The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the states based on the allocations received by the central government. "Bharat Biotech confirms direct supplies of COVAXIN to the following state govt's since 1/5/21, based on the allocations received by GoI. Requests have been received from other states, & will be processed for distribution based on availability of stocks 24x7," Ella tweeted. The company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana, Uttar Pradesh and West Bengal. On April 29, Bharat Biotech announced a cut in the price of 'Covaxin' for states to Rs 400 per dose from the earlier Rs 600 per dose. This followed widespread ..

After just Rs 18,000 cr profits in a decade, Serum, Bharat Biotech may earn big with Covid

For both companies, the pandemic presents a once-in-a-lifetime opportunity to earn hundreds of crores of rupees that could be ploughed back to fund further research and capacity expansion

Covid-19 2nd wave: Reports of no fresh vaccine order incorrect, says govt

Business Standard had reported in Monday's edition of the newspaper that the Centre had not yet placed fresh orders with the vaccine manufacturers. We stand corrected.

Bharat Biotech follows SII, reduces Covaxin price to Rs 400 for states

Earlier, the Bharat Biotech vaccine was priced at Rs 600 a dose

Serum cuts Covishield price by 25% for states, no change for pvt hospitals

Bharat Biotech is yet to announce any change in prices of Covaxin

India's Covaxin vaccine 'very important antidote' against Covid: Dr Fauci

Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus, NYT reports separately.

In a nation of inequalities, India's vaccine strategy is bad economics

Free, universal access to inoculation could prepare India better for a third Covid-19 resurgence.

After states' objection, Centre asks vaccine manufacturers to lower prices

SII and Bharat Biotech had announced prices for state government procurement and for institutional sale to private hospitals

State govts begin vaccine price negotiations, eye Rs 150 per dose

States would have to fund procurement from their own budgets and bridge funding from the Centre is unlikely

Coronavirus LIVE: UK dispatches 'life-saving' medical equipment to India

Coronavirus live updates: Bharat Biotech sets price for its Covaxin vaccine; Serum Institute defends the cost of its Covishield shot in the market.

Covaxin to cost Rs 1,200 per dose for private hospitals, Rs 600 for states

Bharat Biotech noted that the manufacturing process was expensive due to low process yields, and that it was important to recover costs to invest in future R&D

Andhra Pradesh places order for 40 mn doses each of Covaxin, Covishield

The Andhra Pradesh government on Saturday placed an order for purchase of 40 mn doses each of Covaxin and Covishield for vaccinating 2.04 crore people in the 18-45 age group from May 1

Bharat Biotech's Krishna Ella wants maximum price for its vaccine

Says the company would like to recover the costs incurred in clinical trials, and other things and reinvest the money into R&D to be ready for future pandemics

Covaxin neutralises the double-mutant coronavirus strain, says ICMR

The B.1.617 or 'double mutant' Indian variant carries two mutations, including the L452R and E484Q

Covaxin shows 100% efficacy against 'severe Covid-19', 78% overall

The Bharat Biotech candidate has also shown 70 per cent efficacy against asymptomatic infections, suggesting that it prevents transmission

Covid vaccine, price and availability after May 1: All you need to know

In this podcast, we take a look at all those important updates related to coronavirus vaccine in a quick time

Coronavirus vaccine shot may cost Rs 1,000 in private market: Sources

Could be priced at Rs 600-650/dose for institutional sales

Prioritise country first, PM Modi tells Covid-19 vaccine makers

"He has asked the industry to prioritise deliveries to meet the country's needs first and then focus on global supplies," said a person in the know, who did not wish to be named.

Manufacturers look to boost capacity as govt enhances vaccination scope

Firms work to secure raw material locally as imports remain a challenge